Competency information
Details
Interpret and report on a range of genetic testing in haematological malignancy, including both diagnostic and follow-up (monitoring) analysis.
Considerations
- Interpretation of results including diagnostic and treatment recommendations, taking into account the relationships between chromosome abnormalities/genetic markers, other testing modalities and clinical diagnosis
- Use and critical appraisal of relevant literature and online databases.
- Role of multidisciplinary team (MDT) meetings and guidelines such as Improving Outcomes Guidance and NICE Guidelines
- The role of large scale national and international projects focussed on acquired disease.
- Recognising that all tests have been completed to a satisfactory standard for the referral reason.
- All information has been validated as correct.
- Selection of correct report template for referral reason.
- Recommendations for further referral (e.g. clinical genetics). Identify the requirements for any follow up testing, the testing methods available and the appropriate choice of test. Describe any limitations.
- Use of correct scientific and clinical terminology
- Use of relevant databases and literature in the interpretation of results.
- Communication of complex scientific information to clinicians and patients.
- Best practice guidelines compared with laboratory practice and any differences between the two
- How to identify pertinent EQA schemes; their role and practice, how these are incorporated into laboratory practice and ISO standards for lab participation in EQA schemes.
Relevant learning outcomes
# | Outcome |
---|---|
# 5 | Outcome Analyse the results from genetic and genomic testing inĀ acquired sporadic cancers. |
# 6 | Outcome Interpret and report a range of genetic and genomic testing relevant to acquired sporadic cancer. |